 DOLONEUTIN
|
Géminis Farmacéutica
|
| pregabalina |
Antiepiléptico |
| 150 mg cáps.x 30 | $41.599,00 | (25/11/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $19.021,80 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.989,52 AF $13.609,48 |
|
|
|
|
| 25 mg cáps.x 30 | $8.568,00 | (25/11/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $4.038,10 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $7.262,08 AF $1.305,92 |
|
|
|
|
| 300 mg cáps.x 30 | $59.350,00 | (25/11/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $19.694,15 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $41.488,21 AF $17.861,79 |
|
|
|
|
| 50 mg cáps.x 30 | $21.600,00 | (25/11/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $8.117,95 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.449,24 AF $6.150,76 |
|
|
|
|
| 75 mg cáps.x 15 | $14.500,00 | (28/10/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $5.343,96 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $10.600,45 AF $3.899,55 |
|
|
|
|
| 75 mg cáps.x 30 | $24.673,80 | (25/11/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $12.007,34 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.932,47 AF $4.741,33 |
|
|
|
|
| |
